At the news
? NEUTRALIMPACT 2/10 144 filed Nov 4, 2026 at 16:24 ET
Hans van Houte, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 4,769 shares of common stock, with an approximate market value of $123,136 based on the filing date. The shares were acquired via restricted stock units that vested on October 30, 2026. This represents a relatively small portion of the company's $2.8B market cap and is a routine insider sale.
- Hans van Houte, an officer of Nurix Therapeutics, filed Form 144 on 2026-11-04.
- The proposed sale covers 4,769 shares of common stock.
- Estimated aggregate market value of the proposed sale is $123,135.58.
- Shares were acquired via restricted stock units that vested on 2026-10-30.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access